Rxsight, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rxsight, Inc. (RXST) on December 22, 2025, reporting events occurring on December 16, 2025. The filing addresses the departure of the Company's Chief Financial Officer and related compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to the compensation of the departing officer:
- Consulting Retainers: $15,000 per month for January, February, and March 2026.
- Hourly Rate: $500 per hour for services rendered under the consulting agreement.
- Equity: Outstanding stock options will continue to vest per original terms during the consulting period.
Material Changes
The primary material change is the resignation of Shelley Thunen as Chief Financial Officer (CFO) and principal financial and accounting officer. Her departure is effective upon the sooner of the appointment of her successor or January 31, 2026. She will transition to a consultant role to support the Company.
Outlook, Risks, and Management Commentary
Management has announced a transition plan involving a Transition Agreement and a Consulting Agreement. The consulting term is scheduled to end on December 31, 2026. The Company expects to enter into these agreements effective on Ms. Thunen's employment separation date. No specific risks or contingencies regarding the Company's operations were disclosed in this filing, other than the standard transition of leadership.
Key Facts for Investor Verification
- Confirmation of the appointment date for the new Chief Financial Officer.
- Details of the final fiscal 2025 annual cash bonus determination for the departing CFO.
- Any potential impact on the Company's financial reporting timeline or internal controls during the transition period.
- Verification of the total estimated cost of the transition and consulting agreements.